Annexon Inc (ANNX) Stock Analysis

Annexon Inc (ANNX) is a publicly traded company in the HEALTHCARE sector. It trades at $5.26, carries a market capitalization of $888.03M. This page summarizes the public market data, fundamentals, and frequently asked questions for ANNX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Annexon Inc currently has a Bullish sentiment score of 0.37.

About Annexon Inc

Annexon, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focusing on revolutionary therapies for autoimmune and neurodegenerative diseases. Harnessing its proprietary technology platforms, the company is developing innovative treatments that aim to restore immune balance and enhance neuronal health. With a promising pipeline of drug candidates targeting significant unmet medical needs, Annexon is strategically positioned as a leading innovator with...

GNG Research Analysis

GNG Research scores Annexon Inc (ANNX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANNX.

Frequently Asked Questions

Does ANNX pay dividends?

Annexon Inc (ANNX) does not currently pay a regular dividend.

What is ANNX's market cap?

Annexon Inc (ANNX) has a market capitalization of $888.03M with a current stock price of $5.26.